Showing all 3 results

  • Placeholder
    In Stock

    Darifenacin Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, Hydrophilic Matrix Prolonged-Release Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute physical stability of the controlled-release polymer.

    Active IngredientStrengthPrimary Clinical Function
    Darifenacin Hydrobromide USP/Ph.Eur.
    (Equivalent to Darifenacin base)
    7.5 mg (PR)The Standard Titration & Geriatric Anchor: The definitive, highly efficacious starting and maintenance dose utilized for the vast majority of patients to control OAB symptoms with minimal side effects.
    Darifenacin Hydrobromide USP/Ph.Eur.15 mg (PR)The Severe Refractory Macrodose: High-efficacy therapeutic payload utilized strictly for patients who require greater symptom relief and have demonstrated high tolerability to the 7.5 mg dose.
    ExcipientsHypromellose (HPMC) / Dibasic Calcium Phosphate / Magnesium Stearate / Polyethylene Glycol / Titanium Dioxide / Premium Polymeric FilmHydrophilic PR Matrix / Diluent / Lubricant / Plasticizer / Opaque Film (Engineered specifically utilizing high-viscosity Hypromellose. Upon contact with gastrointestinal fluids, the tablet hydrates to form a thick, gelatinous outer layer that strictly controls the diffusion of the highly soluble hydrobromide salt over a 24-hour period)

    *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic urological dispensing regimens).

  • Placeholder
    In Stock

    Desvenlafaxine Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, Hydrophilic Matrix Extended-Release Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical and physical stability of the controlled-release polymer.

    Active IngredientStrengthPrimary Clinical Function
    Desvenlafaxine Succinate USP/Ph.Eur.
    (Equivalent to Desvenlafaxine base)
    50 mg (ER)The Global Therapeutic Standard: The definitive, highly efficacious starting and maintenance dose utilized for the vast majority of patients suffering from Major Depressive Disorder.
    Desvenlafaxine Succinate USP/Ph.Eur.100 mg (ER)The Severe Refractory Macrodose: High-efficacy therapeutic payload utilized strictly for severe, treatment-resistant depression where maximum norepinephrine reuptake inhibition is required.
    ExcipientsHypromellose (HPMC) / Microcrystalline Cellulose / Talc / Magnesium Stearate / Premium Polymeric FilmHydrophilic ER Matrix / Diluent / Glidant / Lubricant / Film-Coating (Engineered specifically utilizing high-viscosity Hypromellose. Upon contact with gastric fluid, the tablet forms a thick, gelatinous outer layer that slowly erodes over 24 hours, guaranteeing a smooth, flat pharmacokinetic curve to prevent violent nausea and serotonin spikes)

    *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day psychiatric dispensing regimens).

  • Placeholder
    In Stock

    Divalproex Sodium Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, Hydrolytically Shielded Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical survival of the intensely hygroscopic active ingredient.

    Active IngredientStrengthPrimary Clinical Function
    Divalproex Sodium USP/Ph.Eur.250 mg (DR / ER)The Titration & Pediatric Standard: The definitive unit utilized for careful initial dose titration in adult bipolar patients or weight-based dosing for pediatric epilepsy.
    Divalproex Sodium USP/Ph.Eur.500 mg (DR / ER)The Neurology Macrodose: Massive therapeutic payload utilized for the aggressive, sustained suppression of chronic complex partial seizures and acute bipolar mania.
    Excipients (Enteric DR Formulation)Microcrystalline Cellulose / Croscarmellose Sodium / Povidone / Methacrylic Acid Copolymer (Eudragit) / Triethyl Citrate / Titanium DioxideDiluent / Superdisintegrant / Binder / Enteric Polymer / Plasticizer / Opaque Film (Engineered specifically utilizing advanced fluid-bed enteric coating to completely shield the highly corrosive valproate compound from the stomach, ensuring the pill only dissolves in the alkaline environment of the small intestine to prevent severe gastric bleeding and vomiting)

    *Pack Sizes: 10×10 Alu-Alu Blisters or Heavy-Gauge HDPE Bottles (Optimized specifically for strict chronic neurology and psychiatry dispensing regimens).